Exciting results from a small study testing a new vaccine to treat the most common form of lung cancer. Early findings show the experimental vaccine wiped out all signs of cancer in a handful of patients and slowed the spread of the disease in others.
The vaccine, called G-VAX, is made from the patient's tumor cells and works by boosting the immune system. The treatment worked best in patients in the advanced stages of their disease and there were few side effects. While these early results are promising, researchers stress that the vaccine is still in the preliminary testing stage and has a number of hurdles to cross before it is considered for approval.
Lung cancer is the leading cause of cancer deaths in the U.S. The research is being led by Baylor University Medical Center in Dallas and is funded by the National Cancer Institute. The findings are published in the Journal of the National Cancer Institute.
All the patients in the study had non-small cell lung cancer. For more information about cancer research studies at the Mary Crowley Medical Research Center at Baylor University Medical Center at Dallas, you can ( click here ).
The economic cost of asthma in the United States is nearly $82 billion a year, federal health officials report.
Time is running out for millions of American kids covered by the Children's Health Insurance Program (CHIP).
While your dog or cat might love the taste of raw meat, a steady diet of it might be a bad idea, a new study warns.
A Mediterranean diet may make seniors less likely to become frail and help them maintain their health and independence, new research suggests.
Even though appendicitis often resolves with the use of antibiotics, the overwhelming majority of Americans would opt for surgery instead, a new survey finds.
Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.